Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20226 (
TATA-binding protein
)
1,297
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Serum response factor
(
SRF
), a transcription factor that binds to the serum response element (SRE) of the c-fos proto-oncogene, activates transcription of an SRE-containing reporter plasmid in vitro. We describe here preincubation experiments which indicate that
SRF
activates transcription by facilitating the formation of active preinitiation complexes. Full activation by
SRF
occurred if
SRF
was preincubated with the general transcription factors. However, if the general transcription factors were preincubated and
SRF
was added subsequently, only poor activation of transcription was observed. This suggests that
SRF
must be present during preinitiation complex formation and that this complex is refractory to activation if
SRF
is absent during its formation. We have fractionated the general transcription factors and found that only a highly purified fraction containing the
TATA-binding factor
TFIID (and other unidentified components) must be present during preincubation for maximal transcriptional induction by
SRF
. This supports a model in which
SRF
activates transcription by affecting the conformation of TFIID bound to the promoter. Also of interest was the finding that recombinant human TFIID expressed in bacteria cannot mediate
SRF
-activated transcription, although it does support basal transcription. These results suggest that
SRF
may affect TFIID via a cofactor or coactivator.
...
PMID:Serum response factor affects preinitiation complex formation by TFIID in vitro. 190 74